Trials / Completed
CompletedNCT01214382
Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass Surgery
A Prospective, Longitudinal Comparison of the Pharmacokinetic Properties of Sertraline Before and After Roux-en-Y Gastric Bypass
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- North Dakota State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to evaluate how the body absorbs and processes the medication sertraline (Zoloft®) before compared to how it is absorbed at two time points after gastric bypass surgery. Participants will be asked to take part in this study at three time points: 1) before their bariatric surgery, 2) at three months following the surgery, and 3) twelve months following surgery. This study will enroll approximately 30 participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sertraline | Single dose sertraline 100 mg, tablet and solution |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2010-10-05
- Last updated
- 2016-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01214382. Inclusion in this directory is not an endorsement.